INDEX VALUES   |

Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index


LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

LSCIBPS&P 500
Prior Day Closing Value7695.944771.02
Prior Day Change %-0.58%-0.59%
Current Value
Current Day Change %-0.70%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Sep 22, 2017)


No. of Constituents 36
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Sep 22, 2017)


Top 10 Constituents (Sep 22, 2017)


Constituent Ticker Weight
Acadia Pharmaceuticals Inc ACAD 3.53%
Sarepta Therapeutics Inc SRPT 3.50%
Acorda Therapeutics Inc ACOR 3.49%
Vanda Pharmaceuticals Inc VNDA 3.45%
Neurocrine Biosciences Inc NBIX 3.44%
Enanta Pharmaceuticals Inc ENTA 3.42%
Gilead Sciences Inc GILD 3.31%
Halozyme Therapeutics Inc HALO 3.26%
Retrophin Inc RTRX 3.24%
Biogen Inc BIIB 3.23%
Data Updated Daily
Download All Constituents